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The vertebrate body is made by progressive addition
of new tissue from progenitors at the posterior
embryonic end. Axial extension involves different
mechanisms that produce internal organs in the
trunk but not in the tail. We show that Gdf11 signaling
is a major coordinator of the trunk-to-tail transition.
Without Gdf11 signaling, the switch from trunk to
tail is significantly delayed, and its premature activa-
tion brings the hindlimbs and cloaca next to the fore-
limbs, leaving extremely short trunks. Gdf11 activity
includes activation of Isl1 to promote formation of
the hindlimbs and cloaca-associated mesoderm as
the most posterior derivatives of lateral mesoderm
progenitors. Gdf11 also coordinates reallocation
of bipotent neuromesodermal progenitors from the
anterior primitive streak to the tail bud, in part by
reducing the retinoic acid available to the progeni-
tors. Our findings provide a perspective to under-
stand the evolution of the vertebrate body plan.
INTRODUCTION
Vertebrates display a large diversity of body shapes and sizes.
Despite such morphological variations, their primary body axis
is always generated from head to tail through a similar principle,
consisting of the progressive addition of new tissue at the poste-
rior end of the embryo (reviewed in Stern et al., 2006; Wilson
et al., 2009). This process requires a fine balance between the
maintenance of progenitor pools and the continuous production
of cells that form the different body structures. Cells leaving the
axial progenitor pools at different stages during the elongation
process execute patterning and differentiation programs that
are specific to each particular axial level. Quantitative and qual-
itative differences in these general processes are the basis of
vertebrate body shape diversity. One of themost important com-
ponents of anterior-posterior (AP) regional variation is the portion
of the postcranial body occupied by the neck, trunk, and tail. For
instance, the prototypical snake’s body has a very long trunk and
rather short neck and tail. In contrast, birds exhibit long necks
and reduced tails, whereas some lizards have fairly short necks
and trunks, but very long tails. Thus, elucidating themechanisms
that control this regional organization is essential to understand
the evolution of the vertebrate body plan.DevelThe transition from trunk to tail is one of the key elements in AP
organization of the vertebrate body. Whereas the trunk holds
most of the vital and reproductive organs, the tail is basically
composed of vertebrae and its associated muscles. These dif-
ferences reflect major changes in developmental mechanisms
during axial extension. Embryologically, trunk tissues require
extensive contributions from all three germ layers, including
the lateral and intermediate mesoderm, which in concert with
the endoderm, originate the trunk-associated organs (Carlson,
1999). Conversely, tail tissues are mostly derived from the para-
xial mesoderm and ectoderm. This means that the trunk-to-tail
transition marks the posterior end of the endoderm, as well as
of the lateral and intermediate mesoderm. Interestingly, this is
associated with the induction of the hindlimb buds from the
lateral mesoderm and with the activation of molecular programs
in the ectoderm, hindgut endoderm, and ventral lateral meso-
derm, resulting in the production of the embryonic cloaca (Suzuki
et al., 2009). The consequences of this embryological feature are
still patent in the adult animal as the end of the trunk typically cor-
relates with the position of the cloaca and its derivatives, and of
the hindlimbs, if the animal has them.
The trunk-to-tail transition is also associated with a switch in
the mechanism guiding embryonic axial growth. Trunk formation
is driven by a midline structure called the primitive streak (PS), in
which ingressing cells from the epiblast generate the embryonic
mesoderm and definitive endoderm (Psychoyos and Stern,
1996; Tam and Beddington, 1987; Wilson and Beddington,
1996). Conversely, caudal growth during tail formation is associ-
atedwith the activity of the tail bud (Kanki andHo, 1997; Schoen-
wolf, 1977). This change in the mode of axial growth involves the
relocation of axial progenitors from the PS and adjacent areas of
the epiblast to the caudal neural hinge (CNH) at the posterior end
of the tail bud (Cambray and Wilson, 2002, 2007; Wilson and
Beddington, 1996).
The mechanisms controlling the trunk-to-tail transition are
largely unknown, despite their importance. As for other aspects
of AP regional patterning, most of the studies on differences
between the trunk and the tail have focused on their associated
skeleton (reviewed by Mallo et al., 2009, 2010; Wellik, 2007). In
the adult animal, the trunk typically expands through the thoracic
and lumbar segments of the vertebral column, whereas the
transition to the tail occurs through the sacrum and the tail itself
is associated with caudal vertebrae. Regional specification of
these skeletal segments results from the execution of distinct
patterning programs during differentiation of the somitic
mesoderm (reviewed by Mallo et al., 2009, 2010; Wellik, 2007).
Although coordinated with the networks controlling otheropmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Inc. 451
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Control of Trunk-to-Tail Transitionaspects of trunk and tail development, these mechanisms
mostly operate within the paraxial mesoderm and cannot
account for such transition. Indeed, a variety of genetic experi-
ments in the mouse indicate that the embryo can undergo major
patterning changes in their axial skeletons with very little or no
obvious effects on hallmarks of the trunk-to-tail transition, such
as the position of the hindlimbs (Carapuc¸o et al., 2005; McIntyre
et al., 2007; Vinagre et al., 2010; Wellik and Capecchi, 2003).
There are a few mutant phenotypes, however, that are sugges-
tive of a simultaneous alteration in several aspects of the
trunk-to-tail transition. Those associated with the inactivation
of Gdf11 signaling in mice are particularly interesting, as they
produce a global anteriorization of the axial skeleton (Andersson
et al., 2006; Essalmani et al., 2008; McPherron et al., 1999; Oh
et al., 2002; Szumska et al., 2008). Mutants for members of
this pathway generally present 16–18 thoracic and seven to eight
lumbar segments instead of the wild-type 13 and 6 vertebrae,
respectively. In these mutants, transformations in the axial skel-
eton are associated with a posterior displacement of the hin-
dlimbs by approximately six to eight vertebral units (Andersson
et al., 2006; McPherron et al., 1999; Oh et al., 2002; Szumska
et al., 2008).
Here, we show that Gdf11 signaling is a major regulator of the
trunk-to-tail transition during vertebrate development. Whereas
loss of Gdf11 delays the specification of the cloaca and the
induction of the hindlimbs, precocious activation of Gdf11
signaling in the epiblast using a constitutively active form of its
receptor, Alk5CA, produces a remarkable anteriorization of these
structures, with a concomitant reduction in trunk length. Strik-
ingly, by using different promoters, we show that this activity is
required in the axial progenitors of the epiblast and not in the
derived mesoderm. We present evidence that the switch from
trunk to tail progenitors requires a combination of several pro-
cesses. These include activation of Isl1 in the progenitors for
the lateral mesoderm, which results in the induction of the hin-
dlimb buds and cloacal tissues. The regulation of Isl1 expression
by Gdf11 signaling seems to be mediated by direct control of a
relevant enhancer of Isl1 that is specifically active during this
transition. Gdf11 signaling is also involved in the orderly reloca-
tion of the bipotent neuromesodermal (N-M) progenitors from
the PS to the tail bud, a process that requires inactivation of ret-
inoic acid signaling.
RESULTS
Loss of Gdf11 Delays Trunk-to-Tail Transition in Mice
Gdf11mutant newborn animals present anterior homeotic trans-
formations along the axial skeleton, with posterior displacement
of the hindlimbs by six to eight vertebrae (McPherron et al.,
1999). Analysis of these mutants at embryonic day (E)11.5
revealed that the hindlimb buds were indeed more posteriorly
located, producing an increased interlimb (trunk) region by five
or six somites when compared to wild-type embryos (Figures
1A and 1B). At this stage, Gdf11 mutant hindlimbs were visibly
smaller than those of their wild-type littermates (Figures 1A
and 1B), which contrasted with their normal morphology at
E18.5 (Figures S1A and S1B available online). Embryonic staging
based on hindlimb morphology (Boehm et al., 2011) revealed
that the hindlimbs of E10.5 and E11.5 Gdf11 mutant embryos452 Developmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Icorresponded to those of younger wild-type embryos by
6 and 17 hr, respectively (Figure 1C). This observation raised
the possibility that hindlimb specification is delayed in Gdf11
mutant embryos. Consistent with this hypothesis, analysis of
Tbx4 expression, an early hindlimb marker (Gibson-Brown
et al., 1996), revealed that the hindlimb fields were first identified
at an axial level five to six somites more posterior in Gdf11
mutants than in wild-type embryos (Figures 1D and 1E). These
results suggest thatGdf11 is involved in establishing the position
at which the hindlimb is induced along the AP axis.
Given the correlation between the hindlimbs and the trunk-to-
tail transition, the above results suggest that Gdf11 signaling
plays a fundamental role in setting this transition. Consistent
with this, other hallmarks of the trunk-to-tail transition were
also posteriorly displaced in Gdf11 mutants, compared with
wild-type littermates. In particular, we examined both
endodermal (Shh and Fgf8 expression) (Figures 1F–1I) and
mesodermal (Isl1 and Raldh2 expression) (Figures 1J, 1K, and
S1C–S1F) components of the developing cloaca. In Gdf11
mutants, these markers were expressed next to the posterior
end of the hindlimb buds, similar to what was observed in wild-
type embryos, revealing that the primordium of the cloaca was
also located at a more posterior absolute axial level. In addition
to the posterior displacement of the hindlimb buds and the
cloaca, formation of other tissues and structures typically asso-
ciated with the trunk was caudally extended in Gdf11 mutant
embryos. For instance, expression of Pax2 and Raldh2 revealed
a posterior elongation of the intermediate mesoderm, which
is the precursor of the urogenital tract (Figures 1L, 1M, S1C,
and S1D). Similarly, the visceral lateral mesoderm extended to
more caudal levels, as evidenced by the expression ofWnt2 (Fig-
ures 1N and 1O). Altogether, these results show that the trunk-
to-tail transition was posteriorly displaced in Gdf11 mutants
and that this was associated with a concomitant extension of
trunk-associated tissues to cover the body up to the cloacal
level. They also indicate that the alterations observed in the axial
skeleton of these mutants (McPherron et al., 1999) are just one
manifestation of a more global deregulation of AP patterning
processes.
Alk5 Activation in the Epiblast Anteriorizes
the Trunk-to-Tail Transition
To explore whetherGdf11 signaling is able to dominantly control
the trunk-to-tail transition, we took a gain of function approach in
mouse embryos. Genetic and biochemical experiments revealed
that Gdf11 first binds Acvr2b to form a complex that then acti-
vates Alk5 (also known as Tgfbr1) to initiate a signaling cascade
mediated by Smad2 (Andersson et al., 2006; Ho et al., 2010; Liu,
2006; Oh et al., 2002). It has been suggested that the start of
Gdf11 functional activity is determined by Alk5 availability, which
in axial tissues seems to start at around E9.0 (Andersson et al.,
2006). Therefore, for our gain of function experiments we pro-
duced transgenic embryos expressing a constitutively active
version of Alk5 (Alk5CA), which signals independently of the
ligand (Wieser et al., 1995).
We first expressed Alk5CA using an enhancer element of the
Cdx2 gene (Cdx2P-Alk5CA transgenics), which has been shown
to drive expression in the posterior epiblast and PS (Benahmed
et al., 2008; Gaunt et al., 2005). Activity of this enhancer wasnc.
Figure 1. Posterior Displacement of the
Trunk-to-Tail Transition in Gdf11 Mutant
Embryos
(A and B) Gross morphology of wild-type (A) and
Gdf11 mutant (B) embryos at E11.5. The smaller
size of the hindlimb is evident in the mutants. The
size (in somite units) of the interlimb area is
indicated.
(C) Estimation of the embryonic age of E10.5
and E11.5 wild-type and Gdf11/ embryos
according to the size of the hindlimbs.
Results are shown as the mean ± SEM. ***p <
0.0001.
(D and E) Estimation of the position of hindlimb
induction in wild-type (D) and Gdf11 mutant (E)
embryos (evidenced by Tbx4, arrows) with
respect to the somite number (evidenced by
Uncx4.1).
(F and G) Endodermal component of the cloaca
in E11.5 wild-type (F) and Gdf11 mutant (G)
embryos, labeled by Shh (arrow).
(H and I) Cloacal/urethral epithelium in E11.5 wild-
type (H) and Gdf11 mutant (I) embryos, revealed
by Fgf8 (arrow). Gdf11 mutant embryos exhibited
increased expression of Fgf8 in the tail bud
(arrowhead).
(J and K) Identification of the mesodermal
component of the developing cloaca at E10.5 by
Isl1 expression (arrow) in wild-type (J) and Gdf11
mutant (K) embryos. The asterisk indicates the
position of the hindlimb.
(L and M) Extended formation of intermediate mesoderm, identified by Pax2 (indicated by the arrows), until the posterior part of the hindlimb (asterisk) in E10.5
wild-type (L) and Gdf11 mutant (M) embryos.
(N and O) Identification of the visceral lateral mesoderm byWnt2 expression in wild-type (N) and Gdf11mutant (O) embryos. The brackets show the expression
area close to the hindlimb.
See also Figure S1.
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posterior to the forelimb bud level, although the forelimb progen-
itors were themselves mostly not targeted by the enhancer
(Figures S2A–S2C). Cdx2P-Alk5CA embryos exhibited strong
phenotypes affecting posterior embryonic growth (n = 22 out
of 37 transgenics), which could be classified in two groups.
The most severe phenotypes (n = 12) included a drastic axial
truncation leaving very little tissue posterior to the forelimbs (Fig-
ures S2D and S2E). This phenotype did not permit the analysis of
patterning processes in the trunk region of these embryos.
Another group of Cdx2P-Alk5CA embryos (n = 10), however,
exhibited milder phenotypes, extending their AP axis beyond
the forelimb bud level. These embryos had short bodies but con-
tained clearly recognizable hindlimbs and tails and preserved
fairly normal overall regional organization (Figure 2). Interestingly,
their hindlimbs were located very close to the forelimbs, leaving
extremely short trunks spanning 0–6 misshapen somites in
contrast to the typical 12–13 somites observed in wild-type
E10.5 embryos. The position of the anteriorized hindlimbs was
often asymmetric and in one transgenic embryo the hindlimb
buds were duplicated (Figure 2L). In these embryos, the cloaca
also developed in a more anterior location, maintaining its rela-
tive anatomical position with respect to the hindlimbs (Figures
2E–2H). Globally, these phenotypes were essentially the oppo-
site to those observed inGdf11mutant embryos, thus reinforcing
the important role of Gdf11/Alk5 signaling in establishing theDevelposition of the trunk-to-tail transition. We were not able to
recover any affected Cdx2P-Alk5CA transgenic at a stage that
allowed direct evaluation of AP patterns in the axial skeleton.
However, the anterior expression boundaries of Hoxa9 and
Hoxc10 at E10.5 were anteriorized, maintaining their position
relative to the hindlimb bud (Figures 2I–2L), indicating altered
AP patterns also in the paraxial mesoderm and neural tube.
This observation is consistent with previous Gdf11 gain of func-
tion experiments in chicken embryos (Liu, 2006). Altogether,
these results indicate the existence of a global and coordinated
posteriorization of the body plan of Cdx2P-Alk5CA transgenic
embryos that involves tissues from all germ layers.
It has been reported that the Cdx2 enhancer used in these
experiments is active in both the axial progenitor-containing
posterior epiblast and in the underlying mesodermal compart-
ments (Benahmed et al., 2008). To evaluate if the phenotypes
observed in the Cdx2P-Alk5CA transgenics derived from Alk5
activity in the epiblast or in the mesodermal compartments, we
overexpressed Alk5CA in the paraxial mesoderm using the Dll1-
mesodermal (msd) enhancer (Beckers et al., 2000) and in the
lateral mesoderm using a Hoxb6 enhancer (Becker et al.,
1996). We could not identify any abnormality in any of these
transgenics (n = 21 and n = 22, respectively), indicating that
the phenotypes observed in Cdx2P-Alk5CA transgenics are
most probably derived from the activation of Alk5 signaling in
the epiblast and not in the derived mesodermal compartments.opmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Inc. 453
Figure 2. Anteriorization of the Trunk-to-Tail Transition in Cdx2P-Alk5CA Transgenic Embryos
(A and B) Labeling of the lateral mesoderm and hindlimbs with Hand2 in E10.5 wild-type (A) and Cdx2P-Alk5CA (B) embryos.
(C and D) Labeling of the visceral lateral mesoderm (arrow) with Wnt2 in E10.5 wild-type (C) and Cdx2P-Alk5CA (D) embryos.
(E and F) Labeling of the mesodermal component of the cloaca (arrow) with Isl1 in E10.5 wild-type (E) and Cdx2P-Alk5CA (F) embryos.
(G and H) Labeling of the endodermal component of the cloaca (arrow) with Shh in E10.5 wild-type (G) and Cdx2P-Alk5CA (H) embryos.
(I and J) Expression of Hoxa9 in E10.5 wild-type (I) and Cdx2P-Alk5CA (J) embryos. Arrows mark the anterior limit of expression in the neural tube.
(K and L) Expression ofHoxc10 in E10.5wild-type (K) andCdx2P-Alk5CA (L) embryos. Arrowsmark the anterior limit of expression and the red arrowhead indicates
ectopic expression in the neural tube of the transgenic embryo. In all panels the position of the hindlimb is indicated with an asterisk except for (H), where it is
indicated with a bracket.
See also Figure S2.
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is a keymodulator of the transition from trunk to tail in themouse.
In addition, they show that this signaling is required in the
epiblast and it is therefore very probable that it primarily acts
on the axial progenitors. This suggests that Gdf11 signaling
might be involved in the modulation of the different functional
changes in these progenitors driving their switch from making
trunk to tail tissues.
Altered Tail Bud Organization in Gdf11Mutant Embryos
A typical characteristic ofGdf11mutant skeletons is their trunca-
tion at the sacral/caudal level (McPherron et al., 1999). In midg-
estation embryos, we found that the tails of Gdf11 mutant
embryos exhibited variable phenotypes, typically being distally
thinner than in wild-type embryos and duplicated in a proportion
of them (Figures S3A and S3D). T (Brachyury) was expressed at
the tip of both tail tips (Figure S3D), indicating that the duplicated
tail might have resulted from a splitting of the posterior orga-
nizing area. Therefore, we investigated the transition from PS
to tail bud in Gdf11 mutant embryos. At E9.5, we already
observed deviations from the normal T expression pattern in
Gdf11/ embryos, as transcripts for this gene were distributed
in a broader domain that extended anteriorly through the pro-454 Developmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Ispective tail tip (Figures 3A and 3B). This broadening was pro-
gressively resolved into a distinct domain, which appeared to
segregate by E10.5 (Figures 3C and 3D). In these embryos, distal
thinning of the tail bud started to become evident. At this stage,
expression of other genes functionally associated with the pos-
terior growth area at the tail tip, like Cdx2, Fgf8, andWnt3a, also
exhibited abnormal expression to different extents (Figures
3I–3N). At E11.5, we could observe two or three distinct
T-positive domains along the ventral side of the tails of Gdf11
mutants, from their tip to the posterior border of the hindlimb
buds, even in embryos without split tails (Figures 3E and 3F).
However, at this stage, expression of the other markers was
restricted to the posterior end of the tail or present at differential
levels in the two tail tips when the embryos had a split tail (Figures
1I and S3E–S3H). Interestingly, in allGdf11/ embryos analyzed
at E11.5, we found an ectopic T-expression domain located next
to the hindlimbs, regardless of whether or not their tails were split
(Figures 3F and S3D). This group of cells was negative for other
tested markers of the posterior organizing area (Figures S3F and
S3H). Surprisingly, although these cells were positive for T, we
could not identify ectopic formation of mesodermal tissues in
the caudal end of the Gdf11 mutants. Instead, we observed
ectopic neural tissue ventrally located outside the vertebralnc.
Figure 3. Abnormal Posterior Growth Zone
in Gdf11 Mutant Embryos
(A and B) T expression in E9.5 wild-type (A) and
Gdf11 mutant (B) embryos.
(C and D) T expression in E10.5 wild-type (C) and
Gdf11 mutant (D) embryos.
(E and F) T expression in E11.5 wild-type (E) and
Gdf11 mutant (F) embryos. The arrows in (B), (D),
and (F) indicate the extended anterior expression
through the ventral part of the tail. The arrowhead
in (F) indicates the tip of the tail.
(G) Effect of treatment of Gdf11 mutants with the
RA inhibitor AGN193109 during the trunk-to-tail
transition on the progenitors at E10.5, evaluated
by expression of T.
(H) Effect of treatment of Gdf11 mutants with RA
during the trunk-to-tail transition on the pro-
genitors at E11.5 evaluated by expression of T.
The arrow indicates the ventral ectopic domain
and the arrowhead the position of the tail tip.
(I and J) Cdx2 expression in E10.5 wild-type (I) and
Gdf11mutant (J) embryos. The arrow indicates the
extended anterior expression through the ventral
part of the tail.
(K and L) Fgf8 expression in E10.5 wild-type
(K) and Gdf11 mutant (L) embryos. The arrow in-
dicates the extended anterior expression through
the ventral part of the tail and the arrowheads the
tail bud tip, with upregulation in the Gdf11mutant.
(M and N) Wnt3a expression in E10.5 wild-type (M) and Gdf11 mutant (N) embryos. The arrow indicates the extended anterior expression through the ventral
part of the tail.
(O and P) Comparison of Cyp26a1 expression in wild-type (O) and Gdf11 mutant (P) embryos at equivalent relevant stages of the trunk-to-tail transition
(21 somites for wild-type, 27 somites for Gdf11/ embryos).
See also Figure S3.
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Control of Trunk-to-Tail Transitioncolumn (Figures S3I and S3J), an observation consistent with
previous analysis of both Gdf11 and Pcsk5 mutant embryos
(Szumska et al., 2008). It has been established that the bipotent
N-M progenitors in the tail bud take a neural fate in the absence
of Wnt3a activity (Martin and Kimelman, 2012). Therefore, it is
possible that the ectopic T domain represents a fraction of
such progenitors that failed to become incorporated into the
CNH and differentiated into neural tissue due to the absence of
Wnt3a.
Altogether, these results are consistent with an abnormal
PS-to-CNH transition in the absence of Gdf11 activity, in which
the pool of axial progenitors normally fated to form the CNH
becomes split into several domains instead of a single region
at the tail tip. The split tail might be produced when the number
(or specific characteristics) of progenitors trapped halfway
through the tail is large enough to generate another tail bud,
eventually creating a secondary ventral tail.
Gdf11 Is Required to Reduce RA Levels during
the Transition from PS to CNH
It has been reported that the tail truncation of Gdf11/ fetuses
can be partially rescued by pharmacological inhibition of retinoic
acid (RA) signaling (Lee et al., 2010). The timing of the effective
treatment fits with the PS to CNH transition, which raises the
possibility that the tail rescue may result from the recovery of
this process. To test this possibility, we analyzed how treatment
with the RA inhibitor AGN193109 affected tail bud development
in Gdf11 mutants. Notwithstanding some degree of variabilityDevel(probably resulting from different efficiencies of the treatment),
the tails of these embryos at E10.5 were consistently longer
and thicker than those of untreated Gdf11/ embryos, some
of them resembling the tails of wild-type embryos (Figure 3G).
In addition, we did not find any embryo with a split tail. T expres-
sion in the caudal end of these embryos also showed some vari-
ability but in most embryos it was restricted to the tail tip without
ectopic T-expressing domains (Figure 3G). These results indi-
cate that inhibition of RA signaling produces a significant rever-
sion of the abnormalities observed in the PS to CNH transition
typically observed in Gdf11 mutants, placing RA signaling as a
key element causing the abnormal behavior of axial progenitors
in Gdf11 mutant embryos.
To further explore this hypothesis, we performed the comple-
mentary experiment and analyzed the effect of increased RA
levels at the time of the PS to CNH transition on the axial progen-
itors of Gdf11/ embryos. At E11.5, RA-treated mutants had
variable tail malformations that were always stronger than those
observed in nontreated Gdf11 mutant embryos (Figure 3H). Tail
morphologies varied from hair-like shapes to the complete
absence of the tail posterior to the hindlimbs, which fit with the
stronger skeletal truncations described for Gdf11 mutants after
similar treatments (Lee et al., 2010). T expression in the posterior
part of these embryos was mostly restricted to the ectopic
ventral domain, whereas expression in the remaining tail tip
was severely reduced (Figure 3H). It should be noted that,
although wild-type embryos can be similarly truncated upon
RA exposure, they require approximately ten times higheropmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Inc. 455
Figure 4. Effect of Hoxb9 on the Trunk-to-Tail Transition
(A and B) The position of the hindlimb was analyzed in E10.5 wild-type (A)
and Cdx2P-Hoxb9 (B) embryos, labeling the somites with Uncx4.1 and the
hindlimb with Tbx4.
(C and D) Skeletal analysis of wild-type (C) and Cdx2P-Hoxb9 (D) fetuses at
E18.5. Indicated are the number of the last rib-containing vertebra (T13), the
number of lumbar vertebra and the position of the first sacral vertebra (arrow).
See also Figure S4 and Table S1.
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Control of Trunk-to-Tail Transitionconcentrations of the drug for an equivalent effect (Kessel,
1992). This indicates that Gdf11 mutants exhibit an increased
sensitivity to RA. The effects that exogenous modulation of RA
signaling has on the axial progenitors of Gdf11 mutants are
consistent with the idea that the distribution of progenitors
between the tail tip and the ectopic domains depends on RA
signaling. Furthermore, these effects suggest that appropriate
PS to CNH transition requires complete block of RA signaling
in these progenitors. These results reinforce the interpretation
that the truncated tail phenotypes observed in Gdf11 mutants
are, at least to some extent, the result of a failure to undergo
proper PS to CNH transition.
Because the strength of the Gdf11/ axial progenitor pheno-
type can be altered by exogenous modulation of RA levels, it is
probable that Gdf11 signaling is required to adjust the amount
of available RA at the posterior embryonic end. Considering
the essential role of Cyp26a1 in RA degradation (Abu-Abed
et al., 2001; Sakai et al., 2001), a possible mechanism for RA
signaling control by Gdf11 activity is to regulate the expression
levels of Cyp26a1 during the trunk-to-tail transition. Consistent456 Developmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Iwith this, Cyp26a1 expression levels were reduced in the poste-
rior end of Gdf11 mutant embryos at the time of the PS to CNH
transition (Figures 3O and 3P). This could be the origin of an
unevenRA distribution along the AP axis, whichwould eventually
result in different pools of progenitors being exposed to RA levels
above or below a critical threshold when they are about to
undergo PS-to-CNH relocation.
Hox Genes Do Not Play a Major Role in Establishing
the AP Position of the Hindlimb
The above results show that RA plays a role in Gdf11 function
controlling the PS to CNH transition. However, inhibition of RA
signaling had no, or only minor, effects on other aspects of the
Gdf11mutant phenotype, including the axial formula and the hin-
dlimb position (data not shown) (Lee et al., 2010). This indicates
that Gdf11 signaling controls the axial position of the trunk-to-tail
transition and the proper formation of the CNH through different
mechanisms.
The alterations in the axial formula can be explained by
abnormal Hox gene expression in the paraxial mesoderm (Fig-
ure S4) (McPherron et al., 1999; Szumska et al., 2008). It is not
clear, however, how Gdf11 signaling controls the changes
related to the lateral mesoderm during trunk-to-tail transition
that lead to the induction of structures such as the hindlimb
buds. Analysis of Hoxa9 and Hoxc10 expression in both Gdf11
mutant andCdx2P-Alk5CA transgenic embryos showed that their
activation followed the altered position of the hindlimbs (Figures
2I–2L and S4), suggesting that Hox genes could control AP
patterning in the lateral mesoderm during the trunk-to-tail transi-
tion. A few mutant phenotypes including genes of the Hox9,
Hox10, and Hox11 groups have been reported to include a slight
posterior displacement of their hindlimbs (Favier et al., 1996;
McIntyre et al., 2007), but they seem too mild to support a major
role for Hox genes in this process. To understand if the absence
of stronger phenotypes resulted from functional redundancies
(as observed for other Hox-dependent processes) we took a
gain of function approach by precociously expressing the Hox
genes of these paralogs in transgenic embryos. Only transgenics
expressing a gene of the Hox9 group (Hoxb9) in the epiblast
showed a slight anterior displacement of the hindlimbs by one
segmental unit (1 somite at E10.5, which was translated into
five instead of six lumbar vertebra at E18.5) (Figure 4). However,
no obvious alterations in the hindlimb position were detected
when Hoxa10, Hoxc10, or Hoxa11 were used in similar experi-
ments (Table S1). Also, combined expression of different Hox
genes did not change the phenotypes obtained with individual
Hox genes (Table S1). Therefore, the results from both gain
and loss of function approaches are not supportive of a major
role of Hox genes in specifying the hindlimb position along the
AP axis during trunk-to-tail transition.
Isl1 Organizes the Terminal Differentiation of Lateral
Mesoderm Progenitors during Trunk-to-Tail Transition
Given the relatively minor effect of Hox genes on positioning the
hindlimb, we investigated other factors that could mediate hin-
dlimb induction by Gdf11 during the trunk-to-tail transition. We
noticed that both Hand2 and Shh expression in the hindlimbs of
Cdx2P-Alk5CA transgenics was not restricted to the posterior
mesenchyme, but extended into more anterior areas of thenc.
Figure 5. The Role of Isl1 in the Trunk-to-
Tail Transition
(A and B) Shh expression in the hindlimb buds of
E10.5 wild-type (A) and Cdx2P-Alk5CA (B) trans-
genic embryos. Expression in the posterior part of
the wild-type hindlimb (arrow) and along the whole
AP extension of the distal part of the transgenic
hindlimb (line) is indicated.
(C and D) External morphology of wild-type (C) and
Cdx2P-Isl1 transgenics (D) at E18.5.
(E–H) Truncated phenotype of Cdx2P-Isl1 trans-
genic embryos at E10.5. (E and F) Staining with
Uncx4.1 (somites) and Tbx4 (hindlimb) to show the
anteriorization of the hindlimb bud of Cdx2P-Isl1
transgenic embryos (F) (8 somites from the fore-
limb bud in this embryo), when compared to wild-
type littermates (E). (G and H) In situ hybridization
with T. Expression in the notochord (N) is observed
in both wild-type (G) Cdx2P-Isl1 transgenic (H)
embryos. However, expression in the tail bud
(arrowheads) is mostly absent from the Cdx2P-Isl1
transgenic embryo. The arrow in (H) indicates the
ectopic end of the T expression domain next to the
hindlimb (indicated with a bracket), which in this
embryo is located six somites posterior to the
forelimb bud.
(I and J) Skeletal staining of wild-type (I) and
Cdx2P-Isl1 transgenics (J) at E18.5.
(K–O) Sagittal sections of E18.5 wild-type (K) and
Cdx2P-Isl1 transgenics (I–O) showing: (K) the
external genitalia (G), together with the indepen-
dent uretra (UT) and rectum (R) in wild-type
embryos; (L) the external genitalia (G) and a com-
bined rectum/urethra (R/UT) in Cdx2P-Isl1 trans-
genics; (M) the convergence of the urethra (UT) and
rectum (R) into a single distal tube (arrow) in the
transgenics; (N) the truncation in the neural tube
(NT) in the transgenics; and (O) the presence of
kidneys in the transgenics. UR, ureter; BL, urinary
bladder.
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Control of Trunk-to-Tail Transitionhindlimb bud (Figures 2A, 2B, 5A, and 5B). Isl1 has been shown
to control a Shh/Hand2 network associated with hindlimb
induction (Itou et al., 2012). This observation, together with
cell tracing studies showing that this gene is specifically acti-
vated in the lateral mesoderm associated with the hindlimb
and ventral lateral mesoderm (Yang et al., 2006), in addition
to genetic experiments indicating that it is involved in early
stages of hindlimb induction (Kawakami et al., 2011; Itou
et al., 2012), suggest a possible role for Isl1 in patterning the
lateral mesoderm during trunk-to-tail transition downstream of
Gdf11 signaling. To test this possibility, we first expressed
this gene using the Cdx2P enhancer in transgenic embryos
(Cdx2P-Isl1 transgenics). Although the observed phenotypes
varied in intensity, these transgenics typically exhibited a
more anterior position of the hindlimbs (Figures 5C–5F), which
at E10.5 could reach a position up to six somites away from
the forelimb buds. In contrast to what we observed in Cdx2P-
Alk5CA transgenics, the anteriorized position of the hindlimbs
in Cdx2P-Isl1 transgenics was associated with a truncation of
the tail bud already evident at E10.5 (strong phenotypes were
observed in 8 out of 15 transgenics at this stage) (FiguresDevel5E–5H). At E18.5, this was reflected in the complete truncation
after the eighth thoracic vertebra affecting both the axial skel-
eton and the neural tube (Figures 5I, 5J, and 5N). However,
these fetuses had hindlimbs with strikingly normal skeletal
morphology, which were ‘‘floating’’ within the soft tissue adja-
cent to the caudal end of the truncated axial skeleton (Fig-
ure 5J). In addition, the digestive and excretory systems of
Cdx2P-Isl1 transgenics had an organized opening to the exte-
rior (Figures 5K and 5L), although the urethra and rectum shared
a common end (Figures 5L and 5M). They also had recognizable
external genitalia (Figures 5K and 5L) and fully developed kid-
neys (Figure 5O). In contrast, we could not identify any sign of
the gonads. These results indicate that the structures derived
from the areas that are normally associated with Isl1-positive
tissues (e.g., the most caudal parts of the lateral and of the
intermediate mesoderm) were largely not affected by the preco-
cious activation of Isl1 in the epiblast. Areas that are normally
not in contact with Isl1 activity, however, like the paraxial meso-
derm, neural tube, and more anterior areas of the intermediate
mesoderm (e.g., those forming the gonads) were strongly
affected by expression of Isl1.opmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Inc. 457
Figure 6. Isl1 Expression Requires Smad Activity
(A) Sequence of the CR2 enhancer of the Isl1 gene. The Fox binding sites are
highlighted in green and the Smad binding sites in red and in orange (the
palindromic site).
(B) Schematic representation of the reporter constructs for the Isl1-CR2
enhancer. The Fox and Smad binding sites are represented by green
diamonds and blue circles, respectively. In the mutant constructs, the Smad
binding sites were mutated.
(C) Isl1 expression in the posterior part of the embryo shortly after the trunk-to-
tail transition.
(D) b-galactosidase expression in Isl1-bgal transgenics in E9.25 embryos.
(E) Absent b-galactosidase expression in Isl1-bgal-DS transgenics in E9.25
embryos. Numbers of positive cases in relation to the total number of har-
vested transgenics is indicated between brackets.
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Control of Trunk-to-Tail TransitionContrary to Cdx2P-Isl1 transgenics, embryos expressing Isl1
in the paraxial (Dll1-Isl1 transgenics, n = 13) or the lateral
(Hoxb6P-Isl1 transgenics, n = 11) mesoderm were indistinguish-
able from their wild-type littermates at E10.5. This indicated
that, similar to Gdf11/Alk5 signaling, Isl1 may affect meso-
dermal AP patterning when activated in the axial progenitors
of the epiblast but not in the mesodermal tissues after their
ingression through the PS. Given that Isl1 expression is associ-
ated with the induction of the most posterior derivatives of the
lateral mesoderm, we hypothesized that this gene might trigger
the terminal differentiation of the trunk progenitors. In the pro-
genitors for the lateral mesoderm, this would be associated
with specific physiological programs (like those resulting in hin-
dlimb induction), but in axial progenitors for tissues normally not
in contact with Isl1 activity, it would simply result in their deple-
tion. To test if this could indeed be the case, we analyzed
T expression in Cdx2P-Isl1 transgenics at E10.5. We found458 Developmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Ithat in these embryos T was still expressed in the notochord
associated with the anterior part of the embryo. However, it
was almost completely absent from the tail bud (Figures 5G
and 5H). This is consistent with the idea of a loss of progenitors
forming neural and paraxial mesodermal structures of the tail
bud. Altogether, these data support the incompatibility between
Isl1 expression and the maintenance of axial progenitors
and suggest a developmental role for Isl1 in the programmed
termination of the lateral mesoderm progenitors as part of the
trunk-to-tail transition.
The observation that Isl1 and Gdf11 signaling are both
required in the axial progenitors to modulate AP patterning of
the lateral mesoderm led us to explore if Isl1 is a direct target
of Gdf11/Alk5 signaling. Kang et al. (2009) have recently charac-
terized enhancer elements involved in the activation the Isl1 gene
in the cardiac progenitors and in the posterior part of the embryo.
We found several putative Smad2 binding sites within one of the
most conserved regions of this enhancer (CR2 in Kang et al.,
2009) (Figures 6A and 6B), suggesting that Isl1 could be a target
of the Gdf11 pathway. In transgenic embryos, CR2 was able to
drive expression of a reporter gene specifically in the caudal
end of the lateral mesoderm (Figure 6D), thus mimicking the
normal expression domain of Isl1 in this area (Figure 6C) (Yang
et al., 2006). Inactivation of all potential Smad sites in this
enhancer rendered it inactive (Figure 6E), indicating that they
are required for enhancer activity. Taken together, our results
identify Isl1 as a direct physiological target ofGdf11 in its activity
to modulate the trunk-to-tail transition during mouse axial
elongation.
DISCUSSION
In this work, we have shown that Gdf11 is a central modulator
of the processes involved in the trunk-to-tail transition in
the mouse embryo. This is supported by both loss- and gain-
of-function experiments. In Gdf11 mutant embryos, the
trunk-to-tail transition (which can be conveniently identified by
the position of the hindlimb and cloaca-related tissues) was
posteriorly displaced, leading to the formation of a longer trunk.
Conversely, precocious activation of Gdf11 signaling using a
constitutively activated form of its receptor Alk5 produced a
strong anterior displacement in the hindlimb position, which
resulted in dramatically shortened trunks. It should be noted
that although delayed, the trunk-to-tail transition still occurs in
Gdf11 mutant embryos. One possible explanation is that
Gdf11 activity is partially compensated by other molecules
that activate the same signaling pathway. A candidate for
such molecule is Gdf8 (Myostatin) as inactivation of this gene
intensifies the Gdf11 mutant phenotype in the axial skeleton
(McPherron et al., 2009). An analysis of the trunk-to-tail transi-
tion inGdf11/Gdf8 double mutants has not been reported. How-
ever, the longer rib cages observed in these embryos, together
with the more anterior axial truncation at the lumbar level, and
the presence of strongly reduced hindlimbs (McPherron et al.,
2009) are compatible with a largely incomplete or absent
trunk-to-tail transition. Alternatively (or in addition), other
signaling pathways can act in parallel during this process, pro-
tecting Gdf11 mutant embryos from a complete block in the
switch from making trunk to tail tissues.nc.
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Control of Trunk-to-Tail TransitionThe Hindlimb and Ventral Lateral Mesoderm as a
Product of Terminal Differentiation of the Lateral
Mesoderm Progenitors
During the trunk-to-tail transition, the axial progenitors relocate
from a position in the PS and adjacent epiblast to the CNH (Cam-
bray and Wilson, 2002, 2007; Wilson and Beddington, 1996).
This relocation does not include all progenitors. In particular,
those for the lateral and intermediate mesoderm, involved in
the genesis of the trunk-associated organs, are not incorporated
into the CNH. Instead, specific differentiation programs are acti-
vated in these progenitors to generate the hindlimbs and the
ventral lateral mesoderm, which interacts with the hindgut endo-
derm to organize the posterior end of several trunk-associated
organ systems. Indeed, even in some snakes, a small hindlimb
primordium is produced in this position that later fails to produce
a full grown member (Cohn and Tickle, 1999). Gdf11 signaling
seems to play a role in this process through a mechanism that
includes activation of Isl1 in the progenitors for the lateral meso-
derm. This is in agreement with lineage tracing experiments
showing that in wild-type embryos, Isl1 becomes specifically
activated in the progenitors of the hindlimb and ventral lateral
mesoderm (Yang et al., 2006). It is also consistent with genetic
experiments showing that hindlimbs are not formed in the
absence of this gene (Kawakami et al., 2011; Itou et al., 2012).
In addition, we showed here that precocious activation of Isl1
in axial progenitors of the epiblast was able to induce the hin-
dlimbs and cloacal tissues at more anterior axial levels, thus
mimicking to some extent the Cdx2P-Alk5CA phenotypes (see
below). Importantly, a conserved enhancer for the Isl1 gene
that activates expression in the most caudal part of the lateral
mesoderm, contains several Smad binding sites that are essen-
tial for its activity, thus establishing a direct connection between
Gdf11 signaling and Isl1 activation. In this context, it should be
noted that activation of this enhancer requires other factors in
addition to Gdf11 signaling. Indeed, this regulatory element is
inactive in the progenitors for the neural tube or paraxial meso-
derm, although Gdf11 signaling is active in this area. Fox genes
are among the best candidates to cooperate with Gdf11
signaling in activating this enhancer because it also contains
Forkhead binding sites that are essential for enhancer activity
(Kang et al., 2009). FoxF1 is one of the prime candidates to
play a physiological role in this process for its expression is
detected in the lateral mesoderm but not in the neural tube
and paraxial mesoderm (Mahlapuu et al., 2001).
One of the most striking characteristics of the Cdx2P-Isl1
transgenics was the totally different effects that Isl1 expression
had on the various axial progenitors. In the progenitors of the
lateral mesoderm, precocious Isl1 activation had surprisingly
little effect on the morphogenesis of the posterior lateral meso-
derm derivatives, other than their induction at a more anterior
axial level. However, Isl1 activation had strong deleterious
effects on the progenitors of more medial tissues, like the noto-
chord, the neural tube, and paraxial mesoderm, which normally
do not express Isl1. Therefore, the phenotype that we observed
in the Cdx2P-Isl1 transgenics might indicate that Isl1 activity has
negative effects on progenitor maintenance, bringing them into
terminal differentiation pathways. In the progenitors of the lateral
mesoderm, the cessation of progenitor renewal is combinedwith
activation of the genetic programs resulting in the formation ofDevelstructures like the hindlimb or the ventral lateral mesoderm.
From this perspective, the hindlimb and cloacal tissues could
represent the product of terminal differentiation of the progeni-
tors for the lateral mesoderm associated with the trunk-to-tail
transition. In Cdx2P-Isl1 transgenics, most axial progenitors
are prematurely exposed to Isl1. In the progenitors for the lateral
mesoderm, this triggered the physiological program at an earlier
developmental stage. However, activation of Isl1 in the precur-
sors of neural tube and paraxial mesoderm led to a block in pro-
genitor maintenance that was not associated with an organized
differentiation program, thus producing the morphological trun-
cation of axial structures.
It should be noted that we never foundCdx2P-Isl1 transgenics
with hindlimbs closer than six somites to the forelimb buds or
with axial truncations anterior to the eighth thoracic segment,
indicating that the competence of the axial progenitors to
respond to Isl1 is not uniform along the AP axis. Considering
that Alk5 can induce hindlimb buds at more anterior levels than
Isl1 when prematurely activated in the epiblast, it is probable
that the competence of the axial progenitors to respond to Isl1
is also provided by Gdf11. Whether this is indeed the case, as
well as the mechanisms mediating this gain of competence,
remains to be determined.
Intriguingly, the skeletal phenotype that we observed in
Cdx2P-Isl1 transgenics is remarkably similar to the clinical char-
acteristics found in patients with severe cases of spinal
segmental dysgenesis (Mahomed and Naidoo, 2009), which
raises the possibility that deregulation of Isl1 expression during
trunk-to-tail transition could be in the origin of this human
syndrome.
Setting the PS-to-CNH Transition
Another of the major processes associated with the trunk-to-tail
transition is the relocation of the N-M progenitors from the ante-
rior PS and adjacent epiblast to the CNH to form the tail bud
(Cambray and Wilson, 2002, 2007; Wilson and Beddington,
1996). Our results indicate that Gdf11 signaling is also involved
in this process and that this activity is mediated by modulation
of RA availability at the posterior embryonic end. In addition,
our data suggest that proper PS to CNH transition requires a
complete block of RA signaling because its pharmacological
inhibition produced a significant recovery of the PS to CNH
reorganization in Gdf11/ embryos. This is consistent with the
phenotype of Cyp26a1 mutant embryos (Abu-Abed et al.,
2001, 2003; Sakai et al., 2001). Indeed, it has been shown that
in the absence of this RA-catabolyzing enzyme, embryos are
exposed to an excess of RA that produces axial truncations at
the lumbo-sacral level, which coincides with the stage when
the PS to tail bud transition is taking place. The expression pat-
terns reported for markers like T or Cdx4 in Cyp26a1 mutant
embryos are compatible with strong alterations in the PS-to-
tail bud transition (Abu-Abed et al., 2003). Our data also suggest
that Gdf11 signaling modulates RA availability by regulating
Cyp26a1 expression. Accordingly, Cyp26a1 levels were lower
in Gdf11 mutants than in wild-type embryos during trunk-to-tail
transition. Interestingly, the observation that Cyp26a1 expres-
sion was reduced, but not completely inactivated in Gdf11
mutants at this developmental stage, may explain the segrega-
tion of the axial progenitors into several domains. In particular,opmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier Inc. 459
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Control of Trunk-to-Tail Transitionprogenitors closer to the tail tip would be surrounded by suffi-
cient Cyp26a1 to protect them from RA. However, the levels of
Cyp26a1 in more anterior areas would fall below the threshold
level required for effective RA clearance, leaving progenitors in
this area exposed to RA. A reduction in Cyp26a1 expression in
the tail of Gdf11 mutants has been previously reported at later
developmental stages, associated with other developmental
processes (Lee et al., 2010), further reinforcing the connection
between Gdf11 signaling and the RA catabolic pathway.
The apparent separation between RA-responding and RA-
nonresponding progenitors observed in Gdf11 mutants suggest
that the PS-to-CNH transition might require activation of stage-
specific characteristics in the axial progenitors (e.g., adhesion
properties) that would target them to specific regions (a progen-
itor niche?) of the posterior embryonic end, eventually gener-
ating a tail bud primordium that organizes posterior embryonic
growth. According to this hypothesis, acquisition of those prop-
erties would require complete downregulation of RA signaling in
these progenitors. Activated RA signaling during the PS to CNH
transition would impair colonization of the tail bud primordium
niche. When the majority of progenitors respond to RA (like
Cyp26a1 mutants, Gdf11 mutants treated with low doses of
RA, or wild-type embryos treated with high RA doses), the tail
bud does not form and severe axial truncations occur at the level
of the trunk-to-tail transition (Abu-Abed et al., 2001, 2003; Kes-
sel, 1992; Sakai et al., 2001; Lee et al., 2010).
EXPERIMENTAL PROCEDURES
Transgenic Constructs, Mice, and Embryos
The Gdf11 mutant strain used in this work has been described previously
(McPherron et al., 1999). The constructs for the production of transgenic
embryos were generated using standard molecular cloning techniques. The
enhancers used for these constructs were a 9.5 kb fragment upstream of the
Cdx2 gene (Cdx2P) (Benahmed et al., 2008), the msd enhancer of the Dll1
gene (Beckers et al., 2000), and the lateral mesoderm enhancer of the Hoxb6
gene (Becker et al., 1996). The Isl1CR2 enhancer (Kang et al., 2009) was ampli-
fied by PCR from mouse genomic DNA using primers 50-TCCTCACACTGGTC
TAACCAG-30 and 50-GGACATCCCCACCCAGCGCTG-30. To produce an
enhancerwithout Smadbinding sites, the different Smad targetsweremodified
to CACA, except for the palindromic target GTCTAGAC that was changed to
CATGCAGG. All these modifications were performed using a PCR-based
mutagenesis strategy and verified by direct sequencing. The wild-type and
mutant Isl1 enhancers were cloned upstream of the adenovirus2 minimal late
promoter and the resulting regulatory elements were inserted upstream the
b-galactosidase cDNA. The Isl1 cDNAwas IMAGEclone40130540. Toproduce
the Alk5CA cDNA, we used IMAGE clone 7098473, corresponding to the rat
gene and changed the threonine 204 for an aspartic acid (Wieser et al., 1995)
using a PCR-based mutagenesis strategy. The mutation was confirmed by
direct sequencing of the cDNA clones. TheCdx2P-creERT construct contained
a tamoxifen-inducible Cre recombinase (Hayashi and McMahon, 2002). All
transgenic constructs contained the SV40 polyadenylation signal in addition
to the regulatory regions and relevant cDNAs.
Transgenic embryos were generated by pronuclear injection of the relevant
constructs according to standard methods (Hogan et al., 1994).Gdf11mutant
embryos were obtained from Gdf11+/ intercrosses. The day that plugs were
found was considered E0.5. In the case of transgenic embryos, E0.5 was the
day after the transfer of injected oocytes. The activity of the Cdx2P enhancer
was estimated by crossing Cdx2P-creERT transgenics with the ROSA26R
reporter line (Soriano, 1999) and pregnant females were treated with 4 mg of
tamoxifen/20 g of body weight, dissolved in corn oil by intraperitoneal injec-
tion. Embryos were collected from pregnant females by cesarean section
and fixed with 4% paraformaldehyde (PFA) in PBS for in situ studies or with
Mirsky’s fixative (National Diagnostics) for b-galactosidase staining.460 Developmental Cell 25, 451–462, June 10, 2013 ª2013 Elsevier ITreatment with RA and RA inhibitor were performed as in Lee et al., (2010)
with slight modifications. Briefly, the stock solution of RA inhibitor
AGN193109 (1 mg/ml in DMSO) was dissolved in corn oil and administered
to pregnant females in three doses of 2 mg/kg of body weight between E7.5
and E9.5. For RA treatments, a 25 mg/ml solution of all-trans RA in DMSO
was diluted in corn oil and was administered at E8.5 by oral gavage at a final
concentration of 10 mg/kg of body weight.
All experiments conducted on animals followed the Portuguese (Portaria
1005/92) and European (Directive 2010/63/EU) legislations, concerning hous-
ing, husbandry, and welfare. The project was reviewed and approved by the
Ethics Committee of ‘‘Instituto Gulbenkian de Cieˆncia’’ and by the Portuguese
National Entity, ‘‘Direcc¸a˜o Geral de Alimentac¸a˜o Veterina´ria’’ (license refer-
ence: 014308).
Phenotypic Analyses and Statistics
Comparison of hindlimb development between wild-type and Gdf11 mutant
embryos was performed using the morphometric system developed by
Boehm et al. (2011). Results were presented as mean ± SEM and compared
using the Student’s t test (p < 0.05 was considered significant). To see the
external morphology of midgestation embryos in greater detail, they were
stained in hydrochloric carmine using amodified protocol fromMachado-Silva
et al. (1998) (see Supplemental Experimental Procedures for details). In situ
hybridization on whole embryos was performed using DIG-labeled probes
as previously described (Kanzler et al., 1998). Skeletal analyses were per-
formed using the Alcian blue/alizarin red staining method as previously
described (Mallo and Bra¨ndlin, 1997). For histological analyses, embryos
were fixed in Bouin’s fixative and embedded in paraffin. Sections (10 mm thick)
were then stained with hematoxylin/eosin using standard histological
methods. Identification of b-galactosidase activity was performed by X-gal
staining according to Carvajal et al. (2001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.devcel.2013.05.009.
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